Ania J Aniol, MD
Psychiatry · Santa Monica
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Mark David Levine MD Professional Corporation · 165 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aniol’s office at (855) 501-1004 to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 036160145Licensed Physician And Surgeon · since 2022 · expires 2026-08-31InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$9,220
Medicare paid this office $9,220 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $3,314 | $60 |
| Psychiatric diagnostic evaluation with medical services | 20 | $3,031 | $132 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,045 | $80 |
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 56 · Women 56% · Health risk score 1.24. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 70% · Depression 67% · COPD 41%.
The office billed $29,015, Medicare allowed $11,682 and paid $9,220; for 111 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 111 | 56 | 1.24 | $29,015 | $9,220 |
| 2023 | 38 | 121 | 56 | 1.33 | $27,798 | $9,694 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Psychiatric diagnostic evaluation with medical services | 28 | $4,000 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,893 | $61 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,490 | $83 |
Medicaid work
$51,519 in 2024
Medicaid paid $51,519 for 749 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychiatric diagnostic evaluation with medical services | 137 | $18,584 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 346 | $14,675 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 154 | $10,130 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 112 | $8,129 |
| 2024 | 749 | 4 | 31 | $51,519 |
| 2023 | 718 | 3 | 28 | $43,128 |
| 2022 | 27 | 1 | 12 | $1,176 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 464 | $18,239 |
| Psychiatric diagnostic evaluation with medical services | 139 | $18,225 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 115 | $6,664 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $1,176 |
Drugs they prescribed that Part D paid
$378
Pharmacies billed $378 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 45) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
45 generic and 0 brand-name prescriptions · $378 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 45 | 23 | 0% (0) | 0% | $378 |
| 2023 | 79 | 33 | 0% (0) | None | $5,235 |
| 2021 | 286 | 32 | 0% (0) | 0% | $16,627 |
| 2020 | 179 | 32 | 0% (0) | None | $21,796 |
| 2019 | 20 | None | 0% (0) | None | $2,584 |
| 2018 | 29 | None | 0% (0) | None | $3,730 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 12 drugs
| Fluphenazine | 11 | $2,580 | $235 |
| Aripiprazole | 16 | $2,408 | $150 |
| Haloperidol Decanoate | 15 | $604 | $40 |
| Mirtazapine | 24 | $425 | $18 |
| Escitalopram | 16 | $392 | $25 |
| Quetiapine | 14 | $256 | $18 |
| Trazodone | 27 | $219 | $8 |
| Benztropine Mesylate | 19 | $134 | $7 |
| Fluoxetine | 18 | $102 | $6 |
| Risperidone | 13 | $92 | $7 |
| Sertraline | 14 | $61 | $4 |
| Citalopram Hbr | 14 | $27 | $2 |
2020: 4 drugs
| Haloperidol Decanoate | 16 | $778 | $49 |
| Trazodone | 21 | $107 | $5 |
| Benztropine Mesylate | 14 | $77 | $6 |
| Sertraline | 11 | $49 | $4 |
Money from drug and device companies
$1,110 in 2025
| 2025 | 12 | 45 | None | $1,110 |
| 2024 | 1 | 1 | None | $31 |
| 2020 | 1 | 1 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $320 | 13 payments
|
| Vanda Pharmaceuticals | Fanapt | $238 | 11 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $108 | 4 payments
|
| Supernus Pharmaceuticals | Qelbree | $108 | 4 payments
|
| Lundbeck | Rexulti | $101 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $54 | 2 payments
|
See all 45 published payments
| Noven Therapeutics | Meals · 2025-12-09 | Xelstrym | $23 |
| Vanda Pharmaceuticals | Meals · 2025-12-01 | Fanapt | $29 |
| Abbvie | Meals · 2025-11-24 | Vraylar | $31 |
| Lundbeck | Meals · 2025-11-18 | Abilify Asimtufii | $27 |
| Abbvie | Meals · 2025-11-17 | Vraylar | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-11 | Caplyta | $19 |
| Vanda Pharmaceuticals | Meals · 2025-11-10 | Fanapt | $25 |
| Abbvie | Meals · 2025-10-27 | Vraylar | $14 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $20 |
| Supernus Pharmaceuticals | Meals · 2025-09-30 | Qelbree | $28 |
| Abbvie | Meals · 2025-09-29 | Vraylar | $27 |
| Bausch Health US | Meals · 2025-09-24 | Aplenzin | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-22 | None | $21 |
| Lundbeck | Meals · 2025-09-09 | Rexulti | $23 |
| Vanda Pharmaceuticals | Meals · 2025-09-02 | Fanapt | $25 |
| Abbvie | Meals · 2025-08-19 | Vraylar | $23 |
| Vanda Pharmaceuticals | Meals · 2025-08-12 | Fanapt | $27 |
| Vanda Pharmaceuticals | Meals · 2025-08-12 | Fanapt | $9 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-04 | None | $22 |
| Abbvie | Meals · 2025-07-29 | Vraylar | $26 |
| Abbvie | Meals · 2025-07-28 | Vraylar | $17 |
| Supernus Pharmaceuticals | Meals · 2025-07-25 | Qelbree | $15 |
| Abbvie | Meals · 2025-07-23 | Vraylar | $9 |
| Abbvie | Meals · 2025-07-21 | Vraylar | $35 |
| Vanda Pharmaceuticals | Meals · 2025-07-08 | Fanapt | $27 |
| Alkermes | Meals · 2025-07-07 | Aristada | $30 |
| Abbvie | Meals · 2025-07-01 | Vraylar | $28 |
| Vanda Pharmaceuticals | Meals · 2025-06-16 | Fanapt | $5 |
| Vanda Pharmaceuticals | Meals · 2025-06-16 | Fanapt | $3 |
| Vanda Pharmaceuticals | Meals · 2025-06-16 | Fanapt | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-16 | Caplyta | $25 |
| Lundbeck | Meals · 2025-06-11 | Rexulti | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-06-02 | Rexulti | $27 |
| Abbvie | Meals · 2025-05-27 | Vraylar | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-19 | Trintellix | $26 |
| Abbvie | Meals · 2025-04-29 | Vraylar | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-28 | Caplyta | $34 |
| Teva Pharmaceuticals USA | Meals · 2025-04-14 | Uzedy | $38 |
| Lundbeck | Meals · 2025-04-08 | Rexulti | $28 |
| Vanda Pharmaceuticals | Meals · 2025-03-11 | Fanapt | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-11 | Caplyta | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-03-03 | Rexulti | $28 |
| Supernus Pharmaceuticals | Meals · 2025-02-17 | Qelbree | $36 |
| Vanda Pharmaceuticals | Meals · 2025-02-03 | Fanapt | $36 |
| Supernus Pharmaceuticals | Meals · 2025-01-06 | Qelbree | $29 |
See earlier years (2024, 2020)
2024: $31
| Vanda Pharmaceuticals | Fanapt | $31 | 1 payment
|
2020: $116
| Iti | Caplyta | $116 | 1 payment
|
Professional record
- NPI
- 1689170003
- Licence
- IL 036.160145Illinois 036160145: Inactive
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Student in a training program (390200000X)
- Mailing address
- 3901 Chrysler Dr Rm 5-A, Detroit, MI, 48201
- NPI first listed
- 2018-04-04
- NPI last updated
- 2022-11-04
- NPI record certified
- 2022-11-04
This is when the NPI record was last certified, not a medical board exam.